← All Conditions ← Immune Overview

Autoimmune Hepatitis

★ CMTO Exam Focus

Autoimmune hepatitis is a chronic inflammatory liver disease in which dysregulated T-cells attack hepatic parenchyma, causing progressive hepatocellular necrosis and fibrosis. Unlike viral hepatitis, it is not caused by an infectious agent. Without treatment (immunosuppressive therapy), it progresses to cirrhosis and liver failure. It primarily affects women (~70%), with a bimodal age distribution (15-40 and post-menopausal).

Recognition

  • Fatigue is the most common presenting complaint. Often the only early symptom
  • Jaundice and right upper quadrant discomfort in moderate-to-severe disease
  • Acute hepatitis presentation: fever, malaise, nausea, anorexia (can mimic viral hepatitis)
  • Signs of cirrhosis in advanced disease: spider angiomata, ascites (abdominal fluid accumulation), hepatomegaly (enlarged liver), palmar erythema
  • Asymptomatic presentation: discovered incidentally on abnormal liver function tests in a significant proportion
  • Associated with other autoimmune conditions: type 1 diabetes, thyroid disease (Hashimoto's, Graves'), rheumatoid arthritis, ulcerative colitis, celiac disease
  • Two types: Type 1 (ANA/ASMA positive, any age) and Type 2 (anti-LKM1 positive, more common in children)

MT Relevance

  • Mild, well-controlled disease: Massage is appropriate with physician clearance. Avoid deep abdominal pressure over the liver
  • Active inflammation or abnormal liver function: Treat with the same caution as moderate liver disease — reduce pressure. Avoid deep tissue, percussion, and abdominal massage
  • Corticosteroid use (virtually all patients): Reduce pressure due to tissue fragility, skin thinning, and osteoporosis risk. Fracture risk with vigorous techniques
  • Immunosuppression (azathioprine, mycophenolate): Apply infection control measures. Avoid treating if the client has active infections. If the therapist has any skin lesions, delay treatment
  • Coagulopathy: If INR is elevated or the client bruises easily, use light effleurage only. No deep friction, cupping, or percussion
  • Cirrhosis/advanced disease: Apply all cirrhosis and portal hypertension precautions — abdominal massage contraindicated. Prone may be impossible with ascites

Required Actions

  • Screen for autoimmune comorbidities (thyroid disease, RA, IBD, type 1 diabetes) at intake — these modify treatment independently
  • Ask about recent liver function tests if the client discloses autoimmune hepatitis. Elevated transaminases and prolonged PT/INR signal active disease and coagulopathy risk
  • Refer to physician if the client reports new jaundice, unexplained bruising, or abdominal swelling

Key Takeaways

  • Autoimmune hepatitis is a chronic inflammatory liver disease caused by immune attack on hepatocytes — distinct from viral hepatitis.
  • Virtually all patients are on corticosteroids and/or immunosuppressants, causing tissue fragility, infection risk, and osteoporosis.
  • Severity determines MT modifications: compensated disease allows gentle massage. Decompensated cirrhosis contraindicates systemic massage.
  • Coagulopathy (elevated INR, easy bruising) and liver enzyme elevation are key indicators that modify pressure and technique choices.
  • Screen for autoimmune comorbidities and ask about recent liver function tests at intake.

Sources

  • Norris, T. L. (2019). Porth's essentials of pathophysiology (5th ed.). Wolters Kluwer.
  • Werner, R. (2020). A massage therapist's guide to pathology (7th ed.). Books of Discovery.
  • Rattray, F., & Ludwig, L. (2000). Clinical massage therapy: Understanding, assessing and treating over 70 conditions. Talus Incorporated.